Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial

類似資料

• Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure
  著者:: Awad, Issam A, 等
  出版事項: (2019)
• Symptomatic Hemorrhagic Complications in Clot Lysis: Evaluation of Accelerated Resolution of Intraventricular Hemorrhage Phase III Clinical Trial (CLEAR III): A Posthoc Root-Cause Analysis
  著者:: Fam, Maged D, 等
  出版事項: (2018)
• Minimally Invasive Surgery plus rt-PA for Intracerebral Hemorrhage Evacuation (MISTIE) Decreases Perihematomal Edema
  著者:: Mould, W. Andrew, 等
  出版事項: (2013)
• Thrombolytic Evacuation of Intracerebral and Intraventricular Hemorrhage
  著者:: Dey, Mahua, 等
  出版事項: (2012)
• Safety and efficacy of minimally invasive surgery plus recombinant tissue plasminogen activator in intracerebral haemorrhage evacuation (MISTIE): a randomised, phase 2 trial
  著者:: Hanley, Daniel F., 等
  出版事項: (2016)